Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03343080 · ClinicalTrials.gov registry record · Phase 2
Lidocaine as an Endotracheal Tube (ETT) Cuff Media
A Phase 2 study of Cardiac Disease, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT03343080: Completed Phase 2 study of Cardiac Disease, sponsored by Mayo Clinic.
NCT03343080 is a Phase 2 study of Cardiac Disease that has completed, run by Mayo Clinic. The registered enrollment target is 32 participants, below the 821-participant average among 24 other Cardiac Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03343080, a Phase 2 study of Cardiac Disease, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers will compare the effects of lidocaine versus air, as a way to fill the breathing tube cuff which is gently inflated to hold in place the trachea (airway) during surgery. Air is the traditional method used to inflate the breathing tube cuff. Researchers wish to find if lidocaine works better than air to facilitate tolerance to the breathing tube (decreased coughing, sore throat, hoarseness). They also want to learn more about its effectiveness for this particular surgical intervention.
Primary Outcome
Total amount of Propofol dose used as measured in total milligrams.
Conditions Studied
Interventions
- OTHER Air
- DRUG 1.8% lidocaine plus 0.76% sodium bicarbonate
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2018-07-27 |
| Est. Completion | 2019-08-01 |
| Phase | Phase 2 |
What the finished NCT03343080 record still lists
NCT03343080 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 821-participant average among 24 other Cardiac Disease trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Cardiac Disease appearing as the primary indexed condition, and to 2 interventions - of which Air is the first listed.
NCT03343080 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03343080 about?
NCT03343080 is a clinical study titled "Lidocaine as an Endotracheal Tube (ETT) Cuff Media". Researchers will compare the effects of lidocaine versus air, as a way to fill the breathing tube cuff which is gently inflated to hold in place the trachea (airway) during surgery. Air is the traditional method used to inflate the breathing tube cuff. Researchers wish to find if lidocaine works bet...
What is the current status of trial NCT03343080?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2018-07-27. Estimated completion is 2019-08-01.
What conditions does trial NCT03343080 study?
This clinical trial studies the following conditions: Cardiac Disease.
What interventions are being tested in trial NCT03343080?
The interventions under investigation include: Air (OTHER), 1.8% lidocaine plus 0.76% sodium bicarbonate (DRUG).
Who is sponsoring clinical trial NCT03343080?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03343080 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03343080's enrollment target sits among peer trials
32 24th of 24 higher than 1 of 24 other Cardiac Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiac Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery
RECRUITING · Phase 2
-
Cardiac Performance System Data Collection Study - Minnesota
RECRUITING
-
A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening
RECRUITING
-
Fresh Autologous Whole Blood Transfusion After Cardiopulmonary Bypass
RECRUITING · NA
-
Rectus Sheath Block in Cardiac Surgery
RECRUITING · NA
-
Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI